References
1. Peiris JS, Tang WH, Chan KH et al. Children with respiratory disease
associated with metapneumovirus in Hong Kong. Emerg Infect Dis. 2003
Jun;9(6):628-33.
2. Centers for disease control and prevention (CDC)
Outbreaks of human metapneumovirus in two skilled nursing facilities
-West Virginia and Idaho. 2011-2012
MMWR Morb Mortal Wkly Rep. 2013 Nov 22;62(46):909-13.
3.Boivin G, Abed Y, Pelletier G, et al; Virological features and
clinical manifestations associated with human metapneumovirus: a new
paramyxovirus responsible for acute respiratory-tract infections in all
age groups
J Infect Dis. 2002 Nov 1;186(9):1330-4.
4. Groome M, Moyes J , Cohen C et al; Human metapneumovirus-associated
severe acute respiratory illness hospitalisation in HIV-infected and
HIV-uninfected South African children and adults.
J Clin Virol. 2015 Aug;69:125-32
5. Hoellein A, Hecker J, Hoffmann D et al; Serious outbreak of human
metapneumovirus in patients with hematologic malignancies.
Leuk Lymphoma. 2016;57(3):623-7
6. Schildgen V, Van den Hoogen B, Fouchier R et al; Human
metapneumovirus: lessons learned over the first decade.
Clin Microbiol Rev. 2011 Oct;24(4):734-54
7. Walsh E, Peterson D, Falsey A ; Human metapneumovirus infections in
adults: another piece of the puzzle.
Arch Intern Med. 2008 Dec 8;168(22):2489-96
8. Nawrocki J, Olin K, Holdrege
M et al;The Effects of Social Distancing Policies on Non-SARS-CoV-2
Respiratory Pathogens
Open Forum Infect Dis. 2021 Mar 17;8(7)
9. Charlson M, Pompei P, Ales K et al; A new method of classifying
prognostic comorbidity in longitudinal studies: development and
validation
J Chronic Dis. 1987;40(5):373-83.
10. Ather M1, Nazim S; Impact of Charlson’s comorbidity index on overall
survival following tumor nephrectomy for renal cell carcinoma
Int Urol Nephrol. 2010 Jun;42(2):299-303.
11. Froehner M, Koch R, Heberling U et al; Validation of a
Questionnaire-Suitable Comorbidity Index in Patients Undergoing Radical
Cystectomy
Urol Int. 2020;104(7-8):567-572.
12. Schmolders J, Friedrich M, Michel R et al;Validation of the Charlson
comorbidity index in patients undergoing revision total hip arthroplasty
Int Orthop. 2015 Sep;39(9):1771-7.
13. Tessier A, Finch L, Daskalopoulou S et al; Validation of the
Charlson Comorbidity Index for predicting functional outcome of stroke
Arch Phys Med Rehabil. 2008 Jul;89(7):1276-83.
14. Frenkel W, Jongerius E, Mandjes-van Uitert M et al; Validation of
the Charlson Comorbidity Index in acutely hospitalized elderly adults: a
prospective cohort study
J Am Geriatr Soc. 2014 Feb;62(2):342-6
15. Valeri A, Robbins-Juarez S, Stevens J et al; Presentation and
Outcomes of Patients with ESKD and COVID-19
J Am Soc Nephrol. 2020 Jul;31(7):1409-1415.
16. Kuswardhani R, Henrina J, Pranata R et al; Charlson comorbidity
index and a composite of poor outcomes in COVID-19 patients: A
systematic review and meta-analysis
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):2103-2109.
17. Setter N, Peres M, M de Almeida B et al; Charlson comorbidity index
scores and in-hospital prognosis of patients with severe acute
respiratory infections
Intern Med J. 2020 Jun;50(6):691-697
18. Boivin G, De Serres G, Hamelin ME et al;An outbreak of severe
respiratory tract infection due to human metapneumovirus in a long term
care facility.
Clin Infect Dis. 2007 May 1;44(9):1152-8.
19. COVID-19 Nursing Home Data
The Nursing Home COVID-19 Public File includes data reported by nursing
homes to the CDC’s National Healthcare Safety Network (NHSN) Long Term
Care Facility. Available at
https://data.cms.gov/covid-19/covid-19-nursing-home-data).
20. Williams JV, Harris PA, Tollefson SJ, et al; Human metapneumovirus
and lower respiratory tract disease in otherwise healthy infants and
children
N Engl J Med. 2004 Jan 29;350(5):443-50.
21. Meyerowitz E, Richterman A, RajeshT, Gandhi R et al; Transmission of
SARS-CoV-2: A Review of Viral, Host, and Environmental Factors
Ann Intern Med. 2021 Jan;174(1):69-79.
22. Greenhalgh T, Jimenez J, Kimberly A Prather K et al; Ten scientific
reasons in support of airborne transmission of SARS-CoV-2
Lancet. 2021 May 1;397(10285):1603-1605.
23. Feldman C, Anderson R; The role of co-infections and secondary
infections in patients with COVID-19
Pneumonia (Nathan). 2021 Apr 25;13(1):5.
24. Yuen Frank Wong H, Yin Sonia Lam H, Fong A et al; Frequency and
Distribution of Chest Radiographic Findings in Patients Positive for
COVID-19
Radiology. 2020 Aug;296(2):E72-E78
25. Menni C, Valdes A, Polidori L et al; Symptom prevalence, duration,
and risk of hospital admission in individuals infected with SARS-CoV-2
during periods of omicron and delta variant dominance: a prospective
observational study from the ZOE COVID Study
Lancet. 2022 Apr 23;399(10335):1618-1624.
Table 1. Clinical characteristics of study patients